Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

COVID-19: AIFA OKs vaccine mix for under-60s (4)

COVID-19: AIFA OKs vaccine mix for under-60s (4)

People to get different jab after first dose with AstraZeneca

ROME, 15 June 2021, 16:48

Redazione ANSA

ANSACheck

- ALL RIGHTS RESERVED

-     ALL RIGHTS RESERVED
- ALL RIGHTS RESERVED

Italian medicines agency AIFA has approved giving people people a mix of different COVID-19 vaccines after the government decided to stop using the AstraZeneca jab with under-60s.
    This means that people younger than 60 who have had their first jab with AstraZeneca are set to get the Pfizer or Moderna vaccine for their second dose.
    Italy has stopped giving the AstraZeneca jab to under-60s, after links to bloods clots in younger people and the death of a 18-year-old woman after she had it.
    The Italian authorities had already recommended AstraZeneca be only given to over-60s, but this was not an outright ban and many regions had been giving it to younger people on a voluntary basis.
    The European Medicines Agency (EMA), however, has reiterated that it has approved the AstraZeneca jab for all adults, saying the benefits outweight the risks.
    Italy's COVID commissioner Francesco Figliuolo said the government was "re-planning" vaccinations with the regions and stressed "we have balanced with 11 regions to mitigate the disruption to citizens".
    He said experts were "studying" the use of other vaccines but the goverment's current plan was "sustainable".
    Campania Governor Vinvcenzo De Luca banned AZ and Jonson & Jonson for the over-60s while Friuli Governor Massimiliano Fedriga said regulatory bodies were "confused" over the AZ jab.
   
   

ALL RIGHTS RESERVED © Copyright ANSA

Not to be missed

Share

Or use

ANSA Corporate

If it is news,
it is an ANSA.

We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.